PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials

INTRODUCTION: Atherosclerosis is the leading cause of cardiovascular disease (CVD), which is one of the most common causes of morbidity and mortality worldwide. Lipid accumulation and inflammation play a crucial role in the pathogenesis of atherosclerosis. Proprotein convertase subtilisin/kexin type...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jichang, Liao, Wanying, Wang, Xue, Xu, Ran, Li, Wei, Li, Wenjing, Liu, Kan, Huang, Kaixun, Ma, Yan, Wang, Tao, Yang, Bin, Jiao, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693878/
https://www.ncbi.nlm.nih.gov/pubmed/36424111
http://dx.doi.org/10.1136/bmjopen-2022-062046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693878/
https://www.ncbi.nlm.nih.gov/pubmed/36424111
http://dx.doi.org/10.1136/bmjopen-2022-062046

Ejemplares similares